Profile of Glasdegib for the Treatment of Newly Diagnosed Acute Myeloid Leukemia (AML): Evidence to Date

Acute myeloid leukemia (AML) is an aggressive hematologic malignancy primarily affecting older adults. Historically, the highest rates of response have been achieved with intensive induction chemotherapy; however, a significant portion of older or unfit adults with AML are unable to tolerate intensi...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Sunil Girish, Stanchina, Michele, Bradley, Terrence J, Watts, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354757/
https://www.ncbi.nlm.nih.gov/pubmed/35937938
http://dx.doi.org/10.2147/CMAR.S195723

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9354757/
https://www.ncbi.nlm.nih.gov/pubmed/35937938
http://dx.doi.org/10.2147/CMAR.S195723

Ejemplares similares